Horizon Investments LLC Purchases 13,310 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Horizon Investments LLC increased its stake in Intuitive Surgical by 72.8% in Q4, purchasing 13,310 shares to own 31,595 shares worth about $17.89 million.
• Intuitive Surgical recently beat estimates with EPS of $2.50 (vs. $2.08) and revenue of $2.77B (up 23% YoY), and analysts have an average rating of Moderate Buy with a mean price target of $581.91.

Horizon Investments LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 72.8% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 31,595 shares of the medical equipment provider's stock after buying an additional 13,310 shares during the period. Horizon Investments LLC's holdings in Intuitive Surgical were worth $17,894,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of ISRG. Draper Asset Management LLC boosted its stake in Intuitive Surgical by 41.9% during the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider's stock worth $2,848,000 after purchasing an additional 1,485 shares during the last quarter. SteelPeak Wealth LLC raised its position in shares of Intuitive Surgical by 28.7% in the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider's stock valued at $18,781,000 after buying an additional 9,364 shares during the last quarter. Atlantic Union Bankshares Corp raised its position in shares of Intuitive Surgical by 19.3% in the third quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider's stock valued at $10,179,000 after buying an additional 3,676 shares during the last quarter. Valley Wealth Managers Inc. lifted its stake in shares of Intuitive Surgical by 52.7% in the third quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider's stock worth $1,826,000 after buying an additional 1,409 shares in the last quarter. Finally, AGF Management Ltd. lifted its stake in shares of Intuitive Surgical by 0.6% in the third quarter. AGF Management Ltd. now owns 464,179 shares of the medical equipment provider's stock worth $207,595,000 after buying an additional 2,575 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 0.0%

Shares of ISRG opened at $457.78 on Friday. The company's 50-day moving average price is $474.86 and its 200 day moving average price is $515.98. Intuitive Surgical, Inc. has a 12-month low of $427.84 and a 12-month high of $603.88. The firm has a market cap of $162.13 billion, a P/E ratio of 55.49, a price-to-earnings-growth ratio of 3.67 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical's revenue was up 23.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.81 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.53 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently issued reports on ISRG shares. Truist Financial dropped their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating for the company in a research note on Wednesday, April 15th. Robert W. Baird boosted their target price on Intuitive Surgical from $575.00 to $610.00 and gave the stock an "outperform" rating in a report on Wednesday, April 22nd. Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. JPMorgan Chase & Co. cut their price target on Intuitive Surgical from $625.00 to $550.00 and set an "overweight" rating for the company in a report on Wednesday, April 22nd. Finally, Barclays set a $651.00 price objective on Intuitive Surgical and gave the stock an "overweight" rating in a research report on Thursday, April 23rd. Eighteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $581.91.

Insider Transactions at Intuitive Surgical

In related news, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amy L. Ladd sold 119 shares of the company's stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the transaction, the director owned 120 shares in the company, valued at $55,620. This trade represents a 49.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 5,906 shares of company stock worth $2,907,726 in the last three months. Company insiders own 0.60% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.